HE advent of image-guided frame-based stereotactic systems (IGFSs) for precise localization and treatment of deep brain lesions revolutionized the practice of neurosurgery. 1, 12, 13, [30] [31] [32] 43 Primarily a tool with which to perform brain biopsies, IGFSs became a means or adjunct to achieving a wide variety of intracranial procedures including craniotomy. 2, 6, 14, 22, 26, 31, [34] [35] [36] [37] [38] 42, 51, 55 Previously unachievable levels of accuracy and reproducibility soon became commonplace as experience and understanding of these technologies grew. However, experience also brought to light the limitations and restrictions imposed by IGFSs, fostering a movement toward the development of surgical navigation systems (SNSs) not reliant on reference frames. 3, 5, 18, 24, 44, [52] [53] [54] [55] 60 Surgical navigation systems (that is, frameless stereotactic systems) were initially developed for, and perfected in, craniotomy surgery, eventually yielding results comparable or superior to frame-based techniques. 4, 5, 17, 19 In our own experience encompassing more than 600 craniotomies and 250 spine operations, SNSs based on sonic or optical digitizer technology have been reliable, and user friendly and have demonstrated reproducible results. [3] [4] [5] Reports on the use of these systems for biopsy and related procedures, however, are few and limited to small series of patients. 20, 28, 39, 56 Encouraged by our experience with this technology, in mid-1994 we began developing a technique to adapt SNSs with scalp-applied fiducial markers for use in image-guided percutaneous brain biopsy and similar point-stereotactic procedures. Special hardware was devised to guide and hold biopsy probes and similar devices, and target/trajectory guidance software was written to augment the usual localization and orientation functions of SNSs.
States Food and Drug Administration for these applications, surgery was performed only after the patient consented to an investigation approved by the Cleveland Clinic Foundation Institutional Review Board.
Instrumentation Hardware
Instrumentation was devised so that it could be adapted to most SNSs that are either commercially available or in development. A multiarticulated arm used for positioning and securing neuroendoscopes (X-large Greenberg instrument holder; Codman & Shurtleff, Randolph, MA) was used to allow facile orientation of the probe while providing rigid fixation during the procedure. A metal block that had been created to hold common stereotactic reducing tubes could then be secured in the jaws of the instrument holder.
The SNS that was used in the early portion of our series has been previously described. [3] [4] [5] Basically, the system is composed of four components: a hand-held probe containing two ultrasonic emitters, a microphone array that is rigidly affixed to the operating room table in proximity to the surgical field, hardware to control and detect timing of signal production and reception, and a colorgraphics workstation equipped with software to calculate and present the location of the probe tip on reconstructed neuroimaging studies (ViewPoint; Picker International, Highland Heights, OH). The tip of the probe was specially constructed to fit snugly in the stereotactic guide block and to engage underlying twist-drill perforations in the skull.
Since December 1996 (after 134 cases had already been treated), the workstation has been coupled to a system that uses light-emitting diodes (LEDs) on the hand-held probe, dual two-dimensional charge-coupled device cameras, and appropriate control hardware. This line-of-sight system offers invisible and silent operation, compared with mechanical arms or sonic systems, and allows for continuous tracking of the head by using an array of infraredemitting diodes mounted to the head holder. The same color-graphics workstation equipped with software written to allow for continuous "real-time" presentation of the probe-tip location in space is used to plan and execute the operative procedure.
Placement of Fiducial Markers
Fiducial markers are applied to allow flexible placement of a head fixation device, orientation of the patient's head at surgery, and surgical trajectory (Fig. 1) . For computerized tomography (CT) scanning, after local areas of skin have been prepared using povidone-iodine, surgical staples are applied with the long axis oriented craniocaudally so as to span the CT slices. For magnetic resonance (MR) imaging, the fiducial sites are marked with indelible ink, and proprietary or commercial MR imaging-compatible fiducial markers are affixed to the skin at these locations.
Imaging Data
Three-dimensional volume sets consisting of either CT or MR imaging data encompassing the surgical field and the fiducial markers are obtained. Images are interpolated into a volume data set containing voxels with dimensions of 1 mm. The fiducial markers are identified, and the cartesian coordinates within this reference coordinate set are recorded. Images are presented in a triplanar format (that is, simultaneous coronal, sagittal, and transverse views) with a window available for display of other imaging studies or reconstruction techniques. A target and (optional) entry point are identified and stored. 8 This is one area in which the flexibility of the frameless stereotactic system provides a distinct advantage. By using the oblique image display on the computer screen and the target and trajectory guidance features, one is able to "march through" each possible entry and trajectory such that the optimal surgical plan is achieved (Fig. 2) . 
Positioning of the Patient
Because the accuracy requirements of performing a stereotactic biopsy procedure generally may be more stringent than those required for craniotomy, rigid head fixation and tracking without displacement of localizing scalp fiducial markers is essential. The patient should be positioned before rigid fixation to ensure that a good "line of sight" is maintained between the wand emitters and the detectors. Although induction of general anesthesia is not necessary for the procedure, we prefer this technique over sedation with local anesthetic to avoid the risk of seizure or self extraction from the fixation device (both of which occurred during IGFS biopsies that were performed by one of the authors [G.H.B.]).
The head is secured in a Mayfield or similar commercially available headholder attached to the operating table. Fixation pins should be placed at a sufficient distance from the fiducial markers such that subsequent tightening of the headholder results in minimal scalp distortion and fiducial marker movement. The frameless stereotactic localizer, or "wand," is used to register the patient's fiducial markers to the preoperative imaging studies, which appear on the intraoperative monitor. At least three fiducial markers are registered, and a best-fit transformation is completed by the computer such that a one-to-one correspondence between the patient and the preoperative imaging is obtained. The accuracy of this conversion is assessed by localizing a remaining fiducial marker as well as a mean fiducial error calculated by the SNS. The procedure begins when the error is brought to 2 mm or less. The patient's hair is then minimally clipped, and the scalp and regional hair are cleansed using an antiseptic solution.
Probe Orientation
After the first 70 cases, we devised a draping scheme by using a sterile eye drape applied to cover the entire surgical field, head, and support apparatus. The flexible Greenberg instrument holder is attached to the Mayfield headholder and positioned near the intended entry site. The guide block (Radionics, Burlington, MA, or Picker) is placed within the jaws of the flexible arm and secured tightly. The frameless stereotactic wand is then passed down through the hole in the guide block until the tip is flush with the skin surface. Target and (optional) trajectory guidance functions are implemented, 8 and the wand is activated. Colored circles or dots (representing the true target and the projection of the actual wand trajectory) are displayed on the one plane perpendicular to the actual wand trajectory that also contains the target. The wand is maneuvered using tilts and translations until the circles are concentric, indicating that the bore of the guide block is "on target" (Fig. 2) . The flexible arm is tightened securely, and the wand is fired again to confirm that proper alignment has been maintained during tightening.
The drill guide tube is passed down through the guide block until it is flush with the skin surface (Fig. 3) . We have found that this is a key step to minimize the risk of undue movement or walking of the drill along the skull. Drilling is performed using a 4.5-mm twist drill (Radionics), which is used to penetrate the skull after a small scalp incision has been made with a No. 15 blade. Although it would be possible to perform the procedure through a smaller bone opening, the 4.5-mm hole allows for more flexibility during the procedure, with negligible additional morbidity. Although the entry-point accuracy could suffer to a small degree, the target-point accuracy is not affected.
The specially designed wand tip is inserted through the guide block and into the twist-drill hole. This process ensures that, if reorientation is necessary, the trajectory will clear the walls of the twist-drill hole. The wand is then activated. If the dot and circle are still concentric, the target "depth" is recorded. If the dots are not in alignment, the guide block and flexible arm are adjusted while maintaining the tip in the twist-drill hole. The wand is reoriented until the dots are once again concentric and the depth is recorded. The wand offset between the shank and the guide block is also recorded (Fig. 3) .
Once the burr hole has been fashioned, a reducing tube (minimum 5 mm) is replaced and the dura is opened with a specially adapted coagulating perforator. This helps to ensure good hemostasis at the dural entry point. If undue bleeding is experienced at this point, equipment is on hand to extend the twist-drill hole to a 14-mm burr hole.
The reducing tube for the biopsy probe is placed. The distance from the top of the reducing tube (minimum 5 mm) is recorded as the reducing tube offset (RTO, Fig. 3 ). The formula that describes the distance from the reducing tube to the target is: true depth = VBPL + depth + RTO Ϫ WO, where VBPL is the virtual biopsy probe length (computer-stored probe length), depth is the depth presented by the SNS, RTO is the reducing tube offset, and WO is the wand offset.
The true depth is marked on the biopsy probe and the probe is passed to the target in standard fashion. Similarly, ventricular catheters, brachytherapy catheters, and depthrecording electrodes can all be placed in this manner.
Rigidity of Flexible Arm
In an effort to determine the spatial stability of the Greenberg flexible arm, phantom studies were conducted with the arm attached to a Brown-Roberts-Wells phantom (Radionics). Twenty-five trials were conducted over a wide range of locations where the cartesian (anteroposterior, lateral, or superior-inferior) coordinate of a probe supported by the arm was recorded. The probe and reducing tube were withdrawn and replaced. The new cartesian coordinates were recorded and the three-dimensional difference in tip location was calculated using a method similar to that previously described. 4 
Statistical Analysis
Nonparametric statistical analysis was performed using the chi-square test with appropriate degrees of freedom.
Results
Two hundred thirteen patients underwent 218 biopsy procedures in which this SNS was used. The average age of the patient was 56 years (range 7-88 years). The target dimension measurements (both maximum and minimum) as well as the target depth were recorded for 168 and 62 of the cases, respectively. The average minimum lesion diameter was 27.7 mm, with a range of 5.4 to 62.7 mm (me-dian 26.5 mm; Fig. 4 ). The average depth from the scalp surface was 39.8 mm, with a range of 21 to 77 mm (median 37 mm; Fig. 5) .
Eight of the 218 biopsy specimens were nondiagnostic (3.7%): five of 208 supratentorial lesions (2.4%) and three of 10 infratentorial lesions (30%, p Ͻ 0.001). The list of histological diagnoses is presented in Table 1 . Patients in whom nonneoplastic diagnoses were made had subsequent clinical courses and radiological findings compatible with their histological diagnoses, according to our previous experience. 62 Complications related to the biopsy procedure occurred in eight cases (seven supratentorial and one infratentorial; p Ͼ 0.25). There were five intracerebral hemorrhages (two of which required craniotomy), two infections, and one wound breakdown after instillation of intratumoral carmustine following biopsy. Both infectious complications occurred prior to the development of the draping scheme described in Clinical Material and Methods. There were only three cases of sustained morbidity, and there were two deaths and one delayed deterioration due to disease progression.
Two surgeons treated the majority of the cases (193 of 218 cases). The three surgeons who performed more than 10 biopsy procedures had complication rates lower than 5%, whereas two of the remaining four surgeons had complication rates greater than 10% (p = 0.15; Table 2 ).
In 23 cases, the biopsy procedure was performed in conjunction with additional procedures (exclusive of craniotomy). Nine of these procedures were brachytherapies, five were computer-assisted endoscopies, four were cyst aspirations, two were instillations of carmustine, two were placements of Ommaya reservoirs, and one was a craniotomy.
Subjectively, patient acceptance of the procedure was excellent; there were few complaints regarding discomfort, as compared with patients undergoing frame-based procedures. Much of this difference in perception is undoubtedly related to the fact that, in the majority of pa- 3 . Drawings demonstrating the steps used for aligning and performing depth calculations for frameless stereotactic brain biopsy. A: The probe tip is placed in the guide block with its point resting on the scalp. The wand is iteratively reoriented until it points directly at the target, as determined by the SNS. The flexible arm is then tightened and proper orientation is again confirmed using the SNS. B: A twist-drill hole is fashioned and the dura is perforated. C: The wand is replaced within the guide block and its tip is engaged into the twist-drill hole. Final reorientation is performed if necessary. If the computer has a stored virtual biopsy probe length (VBPL), this is recorded. The depth to the target from the body of the wand is generated by the SNS, and the wand offset (WO) is measured. D: The wand is removed, and a reducing tube is placed to hold the biopsy probe or other instrument. The reducing tube offset (RTO) is then measured, allowing calculation of the depth from the top of the reducing tube to the target by the formula: Final Depth = VBPL + depth Ϫ WO + RTO. tients in this study, general anesthesia had been induced prior to head fixation. Many frame-based procedures involve rigid frame placement while the patient is awake. No incidence of sustained morbidity as a result of induction of general anesthesia was encountered.
Arm Stability
The three-dimensional error over the range of the Greenberg arm incurred by the simulation of carefully removing the wand and replacing it with a biopsy instrument (Fig. 6 ) in 25 trials was 0.32 Ϯ 0.23 mm (mean Ϯ standard deviation). The maximum three-dimensional error was 0.99 mm, whereas the minimum was 0.1 mm.
Discussion
Stereotactically obtained brain biopsy samples by using SNSs and scalp fiducial markers appears to be a reliable, safe method to obtain tissue for diagnosis of supratentorial intracranial lesions. Previous reports have demonstrated that such systems provide a level of accuracy that is comparable to the most popular frame-based stereotactic techniques, 4, 19 and the accuracy rate for diagnosis of supratentorial lesions of 97.6% supports this assertion.
The results of this study compare very favorably with previous studies of biopsy procedures performed using frame-based stereotactic, CT-guided freehand, and ultrasound-guided technologies. Table 3 contains data from these other studies as well as our own and, in particular, provides details of the incidences of morbidity and mortality as well as the percentages of successful biopsy attempts. Although some general comparisons can be made, one must use caution when interpreting the results of these studies. With regard to our own study, a biopsy procedure was deemed a "success" if the tissue obtained demonstrated clear evidence of a pathological process that supported the clinical and radiological findings; findings such as gliosis and astrocytosis were considered nondiagnostic. Conversely, many of the studies listed in Table 3 regarded the biopsy procedure as a success if tissue representing any pathological process was obtained.
Because the current technology is frameless, the inherent limitations of frame-based systems are avoided. These include the bulk and physical limitations of conventional stereotactic head frames, the discomfort and inconvenience to the patient, and the reliance on complicated geometric calculations of varying transparency to the surgeon. These processes can be unwieldy and nonintuitive, including the logistical problems associated with the task of coordinating frame application, neuroimaging, surgical planning, nursing care, induction of anesthesia, and operating room services on the same day as surgery or use of refixation frames. Additionally, problems associated with spatial distortions arising from weight bearing by the frame 45 are avoided using the frameless system. Our results suggest, however, that the frameless approach by using scalp fiducial markers is not without its own limitations. The procedure seems to become less efficacious when used in the posterior fossa where the rate is 30% for nondiagnostic biopsy specimens. Although the number of posterior fossa biopsies was small (10 cases), this significant difference in diagnostic rate is likely accounted for by the relative mobility of scalp fiducial markers in the posterior portion of the head, the potential for fiducial marker displacement by the headholders used by imaging devices, and the distance of the target tissue from the barycenter of the fiducial marker array. Should these speculations be correct, potential strategies to allow the use of frameless biopsy in the posterior fossa include scanning the patient in the prone position or using skullimplantable fiducial markers as described by Wang, et al., 59 which should obviate the problem at the expense of a more invasive registration technique. Also, early in the series, there were two infectious complications. No infections have occurred since the introduction of a draping scheme in which an eye drape covers all nonsterile hardware.
System Design
The principal design goal of this system was to devise a general method to perform brain biopsy procedures by using frameless stereotactic localization provided by virtually any SNS capable of suitable accuracy. The choice of using sonic technology over LED systems early in this series was made because the former produces signals from true point sources, whereas common LEDs may suffer from refractive anisotropy, limiting accuracy over a wide range of wand/detector orientations. 58 However, sonic technology could not reliably overcome spatial distortions caused by air currents in the operating room, and our system eventually evolved into an LED-based system that allowed even more flexibility in operation with acceptable accuracy.
The use of the flexible instrument holder was chosen because it had a large number of degrees of freedom, was quite rigid when locked, could be operated by one person, and could hold a device (guide block) capable of directing a wide array of stereotactic probes, catheters, and electrodes. The use of the Greenberg arm could be criticized because the cable used to tension-lock the arm into a particular position provides rigidity for further flexion of the arm but little rigidity for further extension. This results in the theoretical potential for error at the step at which the localizing wand is removed and the biopsy instrument is introduced. If the arm is not properly tightened or if prop- er care is not exercised, the alignment of the guide block axis and the target could be lost. Nonetheless, our phantom data and clinical experience demonstrate that when used properly, this potential source of error is not a meaningful problem.
Learning Curve
The data weakly support the notion that there is a learning curve to performing these procedures (Table 2) . We suggest that surgeons become familiar with the general principles and trajectories used for percutaneous brain biopsy before using this technology for that purpose.
In a few cases, correct fiducial marker registration was complicated by unusual scalp mobility with respect to the skull. This situation required the use of a subset of fiducial markers (determined by empirical trials) that led to low error registrations, sometimes by using anatomical fiducial markers. The optimum management of this problem usually required assistance of a surgeon experienced in this technique.
Other and Future Applications
Most frame-based systems lack the interactive capability to point to a structure during the procedure and instantaneously identify its location and key anatomical relationships on preoperative stereotactic CT or MR imaging. The ability to do this makes SNSs adaptable to a variety of operative situations and should help to broaden the scope of interactive surgical navigation. Drainage of abscesses, neuroendoscopy, placement of depth electrodes or radioactive implants, cingulotomies, and thrombolysis of intracerebral hemorrhages have all been successfully performed using the methods described here. 7 The use of skull-implanted fiducial markers 59 should provide the accuracy necessary for functional procedures in deep brain such as ablation or chronic stimulation of the thalamus, globus pallidus, or subthalamic nucleus, although it remains to be demonstrated that the apparatus described here would provide adequate stability for these procedures. Ultimately, coupling frameless SNS technology with intraoperative MR fluoroscopy may allow anatomical or physiological monitoring of such procedures in real time (Fig. 7) .
Conclusions
Stereotactically obtained brain biopsy samples by using frameless stereotaxy (image-guided SNSs) appears to be safe and effective for treating a wide range of lesions across a broad spectrum of sizes and depths when registration is provided using scalp-applied fiducial markers. The rates of diagnostic procedures and complications appear comparable or superior to those obtained in frame-based stereotaxy biopsy series. Extra caution, however, should be exercised when performing biopsies using SNSs for posterior fossa lesions because of regional skin mobility and a greater potential for deficit.
